https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-q3-2024-financial-results/ 2025-02-25T16:36:32+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-regains-compliance-with-nasdaq-listing-requirements/ 2025-02-25T16:37:37+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-enters-oncology-space-with-acquisition-of-prostate-cancer-focused-epicapture/ 2025-02-25T16:38:01+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-strategic-investment-in-novus-diagnostics-to-advance-rapid-sepsis-testing-platform/ 2025-02-25T16:38:26+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-amended-credit-agreement/ 2025-06-13T08:46:59+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-further-strengthens-focus/ 2025-06-13T08:50:50+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-breakthrough-on-cgm/ 2025-06-13T08:52:58+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-publishes-fourth-quarter-2024-results/ 2025-06-13T08:54:46+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-entry-into-a-letter-of-intent-with-bayer/ 2025-06-20T10:18:08+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-q3-2023-financial-results-business-update/ 2025-06-20T10:18:21+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-acquisition-of-the-cgm-assets-of-waveform-technologies-inc/ 2025-06-20T10:18:30+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-to-present-at-emerging-growth-conference/ 2025-06-20T10:19:00+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-application-for-early-sjogrens-syndrome-test-panel-pla-code/ 2025-06-20T10:19:04+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-plc-announces-plan-to-implement-ads-ratio-change/ 2025-06-20T10:19:33+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-fourth-quarter-and-fiscal-year-2023-financial-results-business-updates/ 2025-06-20T10:19:55+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-welcomes-avinash-kale-as-continuous-glucose-monitor-programme-director-to-advance-innovation-and-development/ 2025-06-20T10:20:10+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-strategic-collaboration-with-medical-artificial-intelligence-company-pulseai/ 2025-06-20T10:20:25+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-q1-2024-financial-results-and-reiterates-guidance/ 2025-06-20T10:20:43+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-attending-84th-scientific-sessions-of-the-american-diabetes-association/ 2025-06-20T10:20:58+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-appointment-of-a-new-cfo/ 2025-06-20T10:21:10+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-provides-preliminary-second-quarter-2024-update-and-enters-into-uk-distribution-agreement-with-medscience/ 2025-06-20T10:21:25+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-obtains-an-extension-to-demonstrate-compliance-with-nasdaq-listing-requirements/ 2025-06-20T10:21:38+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-q2-2024-financial-results/ 2025-06-20T10:21:49+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-appoints-diabetes-care-veteran-as-biosensor-marketing-director/ 2025-06-20T10:21:59+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-increased-orders-for-trinscreen-hiv-and-raises-guidance-for-2024-sales/ 2025-06-20T10:22:25+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-appoints-global-life-sciences-leader-as-chief-commercial-officer/ 2025-06-20T10:22:46+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-provides-an-update-on-the-continued-development-of-its-continuous-glucose-monitor-technology/ 2025-06-20T10:23:07+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-to-initiate-cgm-market-study-in-india-in-furtherance-of-intended-collaboration-with-bayer/ 2025-06-20T10:23:18+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-acquisition-of-metabolomics-diagnostics-to-grow-presence-in-maternal-health-market/ 2025-06-20T10:23:30+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-plc-finalizes-effective-date-of-ads-ratio-change/ 2025-06-24T14:11:29+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-secures-key-regulatory-approval-for-offshored-and-outsourced-manufacturing-of-its-flagship-rapid-hiv-test-accelerating-strategic-financial-performance-transformation/ 2025-09-25T12:34:28+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-unveils-cgm-an-ai-native-platform-targeting-the-260-billion-ai-wearable-market/ 2025-09-25T12:44:15+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-launch-of-fda-cleared-new-preeclampsia-testing-service/ 2025-09-25T12:44:38+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-achieves-breakthrough-clinical-trial-results-for-redesigned-cgm-sensor/ 2025-09-25T12:46:20+00:00 https://trinitybiotech.com/press-releases/news/nysdoh-new-preeclampsia-testing-approval/ 2025-09-25T12:48:11+00:00 https://trinitybiotech.com/press-releases/news/trinscreen-local-reg-approval-final/ 2025-09-25T12:49:38+00:00 https://trinitybiotech.com/press-releases/news/paul-tivnan-appointed-non-executive-director/ 2025-09-25T12:51:16+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-plc-announces-plan-to-implement-ads-ratio-change-2/ 2025-09-25T12:52:33+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-regains-nasdaq-compliance/ 2025-09-25T12:53:52+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announced-collaboration-to-advance-epigenetic-analysis-for-epicare-prostate-cancer-test/ 2026-02-11T07:42:04+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-secures-regulatory-approval-for-offshored-and-outsourced-manufacturing-of-uni-gold-rapid-hiv-test/ 2026-02-11T07:45:37+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-expands-global-rollout-of-high-capacity-column-system-for-fda-cleared-hba1c-testing-solution/ 2026-02-11T07:55:20+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-awarded-a-major-order-for-9-million-trinscreen-hiv-tests/ 2026-02-11T07:58:06+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-agreements-to-strengthen-capital-structure-and-support-growth-initiatives/ 2026-02-11T07:59:54+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-secures-regulatory-approval-for-commencement-of-upstream-manufacturing-activities-of-uni-gold-hiv-rapid-test-under-its-offshored-and-outsourced-model-supporting-financial-per/ 2026-02-11T08:35:10+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-glucose-monitoring-innovation-achieves-unique-global-recognition-diabetes-care-premier-hb9210-hba1c-analyser-becomes-the-only-system-awarded-prestigious-ifcc-gold-classificat/ 2026-02-27T07:31:25+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-receives-non-compliance-notice-regarding-nasdaq-global-select-requirement-for-nasdaq-minimum-bid-price-requirement/ 2026-03-06T12:21:05+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-receives-non-compliance-notice-regarding-nasdaq-global-select-requirement-for-minimum-market-value-of-publicly-held-shares/ 2026-05-07T12:32:24+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-secures-25-million-financing-commitment-to-support-growth-initiatives/ 2026-05-07T12:35:17+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-provides-business-and-trading-update/ 2026-05-07T12:36:44+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-further-major-technical-breakthroughs-in-advancing-next-generation-cgm-platform/ 2026-05-07T12:38:23+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-senior-executives-to-attend-attd-2026-to-advance-collaborations-following-strong-progress-in-cgm-program/ 2026-05-07T12:39:48+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-begins-rollout-of-innovative-glucose-monitoring-system-in-key-market-following-regulatory-approval-of-next-generation-premier-hb9210-hba1c-column-system/ 2026-05-07T12:41:48+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-collaboration-with-university-at-buffalo-to-commercialize-novel-biomarkers-for-sjogrens-syndrome/ 2026-05-07T12:44:00+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-announces-successful-clinical-results-for-its-enhanced-epicapture-prostate-cancer-test/ 2026-05-07T12:49:50+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-appoints-jerry-lydon-to-lead-north-america-commercial-operations/ 2026-06-12T09:55:21+00:00 https://trinitybiotech.com/press-releases/news/trinity-biotech-awarded-significant-orders-for-over-2-million-trinscreen-hiv-tests-and-reports-q1-2026-financial-results/ 2026-06-16T14:45:47+00:00